Who owns Douglas Earl Martin?

No ownership or control links for Douglas Earl Martin are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.

What is Douglas Earl Martin's risk level?

WhiteIntel flags Douglas Earl Martin as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.

Where does Douglas Earl Martin appear across sources?

Douglas Earl Martin is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

LIVE · CORPUS

PersonLow

Douglas Earl Martin

Name: Douglas Earl Martin — ownership dossier
Creator: WhiteIntel
License: https://whiteintel.dev/terms
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, Douglas Earl Martin, Person, US

Douglas Earl Martin — US person (sec:0001362155). 4 holdings. Every claim linked to its source.

controls 4 companies

Ownership graph Export .md

JSON / MCPsample

The finding

Controls or directs 4 companies in the resolved graph.

Investigative lead by resolved identity, not a legal determination.

/01

Registry identity

Controls: 4 companies
Risk: Low
Jurisdiction: US

/02

Control & directorships

Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.

Controlled by

None in current sources.

Directorships & controlled companies

Douglas Earl Martin
- Allogene Therapeutics, Inc.· officer· via SEC EDGAR (Form 3/4/5)
- BIOMIMETIC PHARMACEUTICALS INC· officer· via SEC EDGAR

Nothing further is withheld here. The ownership and control links above are everything we have resolved for Douglas Earl Martin — there is no deeper chain behind a paywall. Absence means “not observed in our current sources” — it is not a finding of none.

Monitoring

Coverage of Douglas Earl Martin is still thin in the current sources. Watch it and we'll flag the moment new ownership, filings or risk signals land.

Explore US coverage

WHAT YOU CAN SEEFREE

YOURS NOW · FREE

4 items you can read right now — no account, no payment.

Identity, nationality & aliases
Sanctions, PEP & watchlist detail
Direct connections (1 hop)
Community notes

Nothing further on Douglas Earl Martin is behind a paywall — everything we hold on this subject is already on this page.

/03

People & control

2 parties · 0 current

Every officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.

●
Allogene Therapeutics, Inc.
Also holds roles at 33 other companies
- Chang David Dofficer
- Beneski Benjamin Machinasofficer
- MESSEMER DEBORAH M.director
●
BIOMIMETIC PHARMACEUTICALS INC
Also holds roles at 24 other companies
- LYNCH SAMUEL EUGENEdirector
- BULLOCK LAWRENCE Eofficer
- NOVO A/Stenpercentowner

2 parties · 0 current. Ceased and resigned records are retained as history.

/04

Common questions

Who owns Douglas Earl Martin?: No ownership or control links for Douglas Earl Martin are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.
What is Douglas Earl Martin's risk level?: WhiteIntel flags Douglas Earl Martin as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.
Where does Douglas Earl Martin appear across sources?: Douglas Earl Martin is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on Douglas Earl Martin. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnitchScore.

Loading tips…